Bacuyong, Romeo .
HRN: 21-95-76 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/28/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/28/2022
11/04/2022
IV
600mg
Q8hours
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes